BioStock: CLS initiates new prostate cancer study in France

Clinical Laserthermia Systems is on its way to the market with the TRANBERG system for minimally invasive image-guided focal laser ablation. The company recently announced that it is participating in a French study investigating how MRI can be used together with biopsies to detect residual prostate cancer after focal therapy. The first patient in the study has now been treated.

Read the article at biostock.se:

CLS initiates new prostate cancer study in France - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/